Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

UPCommons. Portal del coneixement obert de la UPC
Publication Contribución de congreso (ConferenceOutput)

A machine learning pipeline for supporting differentiation of glioblastomas from single brain metastases

  • Mocioiu, Victor
  • de Barros, Nuno M. Pedrosa
  • Ortega Martorell, Sandra
  • Slotboom, Johannes
  • Knecht, Urspeter
  • Arús, Carles
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Julià Sapé, Margarida
Machine learning has provided, over the last decades, tools for knowledge extraction in complex medical domains. Most of these tools, though, are ad hoc solutions and lack the systematic approach that would be required to become mainstream in medical practice. In this brief paper, we define a machine learning-based analysis pipeline for helping in a difficult problem in the field of neuro-oncology, namely the discrimination of brain glioblastomas from single brain metastases. This pipeline involves source extraction using k-Meansinitialized Convex Non-negative Matrix Factorization and a collection of classifiers, including Logistic Regression, Linear Discriminant Analysis, AdaBoost, and Random Forests., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

A machine learning pipeline for supporting differentiation of glioblastomas from single brain metastases

  • Mocioiu, Victor
  • de Barros, Nuno M. Pedrosa
  • Ortega Martorell, Sandra
  • Slotboom, Johannes
  • Knecht, Urspeter
  • Arús, Carles
  • Vellido Alcacena, Alfredo
  • Julià Sapé, Margarida
Machine learning has provided, over the last decades, tools for knowledge extraction in complex medical domains. Most of these tools, though, are ad hoc solutions and lack the systematic approach that would be required to become mainstream in medical practice. In this brief paper, we define a machine learning-based analysis pipeline for helping in a difficult problem in the field of neuro-oncology, namely the discrimination of brain glioblastomas from single brain metastases. This pipeline involves source extraction using k-Meansinitialized Convex Non-negative Matrix Factorization and a collection of classifiers, including Logistic Regression, Linear Discriminant Analysis, AdaBoost, and Random Forests., Peer Reviewed, Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolomics of Therapy Response in Preclinical Glioblastoma, a Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

  • Arias-Ramos, Nuria|||0000-0001-8983-6362
  • Ferrer-Font, Laura|||0000-0002-3131-7233
  • Lope-Piedrafita, Silvia|||0000-0002-8127-6425
  • Mocioiu, Victor
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
  • Pumarola i Batlle, Martí|||0000-0002-0935-7941
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
Glioblastoma (GBM) is the most common aggressive primary brain tumor in adults, with a short survival time even after aggressive therapy. Non-invasive surrogate biomarkers of therapy response may be relevant for improving patient survival. Previous work produced such biomarkers in preclinical GBM using semi-supervised source extraction and single-slice Magnetic Resonance Spectroscopic Imaging (MRSI). Nevertheless, GBMs are heterogeneous and single-slice studies could prevent obtaining relevant information. The purpose of this work was to evaluate whether a multi-slice MRSI approach, acquiring consecutive grids across the tumor, is feasible for preclinical models and may produce additional insight into therapy response. Nosological images were analyzed pixel-by-pixel and a relative responding volume, the Tumor Responding Index (TRI), was defined to quantify response. Heterogeneous response levels were observed and treated animals were ascribed to three arbitrary predefined groups: high response (HR, n = 2), TRI = 68.2 ± 2.8%, intermediate response (IR, n = 6), TRI = 41.1 ± 4.2% and low response (LR, n = 2), TRI = 13.4 ± 14.3%, producing therapy response categorization which had not been fully registered in single-slice studies. Results agreed with the multi-slice approach being feasible and producing an inverse correlation between TRI and Ki67 immunostaining. Additionally, ca. 7-day oscillations of TRI were observed, suggesting that host immune system activation in response to treatment could contribute to the responding patterns detected.